CPHI Frankfurt is right around the corner! Are you planning to attend? Are you in need of pharma innovation, formulation development, bioanalysis, clinical trials, quality control or GMP manufacturing? Then come meet us at CPHI in Frankfurt, Germany, from the 1st to the 3rd of November. You will find us at stand #41M21 in Hall 4.1. Otherwise you may contact us at sales@quinta.cz to arrange a visit. Our entire QUINTA-ANALYTICA commercial team will be attending in addition to senior management and most importantly our colleagues from the Conscio Group, Conscio Pharmaceuticals, Gen-Plus GmbH & Co. KG, DiHeSys GmbH and BBA Capitalpartners GmbH. We look forward to seeing you in Frankfurt. #cphifrankfurt #cphi2022

Additional News

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

ALL POSTS